Pharmacology: Drug Use and Safety Guide
Uploaded by
marliobsenares73Pharmacology: Drug Use and Safety Guide
Uploaded by
marliobsenares73Common questions
Powered by AIPharmacodynamics involves the biochemical and physiological study of drugs and their effects on the body, including how the drug interacts with tissues, enzymes, or receptors to produce a therapeutic effect . Pharmacokinetics, on the other hand, involves the study of drug movement through the body, focusing on processes such as absorption, distribution, metabolism, and excretion . Understanding both is crucial for drug development as pharmacodynamics helps determine the desired and undesired effects of the drug, while pharmacokinetics informs on how the drug is processed by the body, allowing for optimal dosing, timing, and delivery method to achieve the best therapeutic outcome while minimizing side effects.
Bioavailability refers to the fraction of an administered drug that reaches the systemic circulation in an unchanged form. Factors influencing bioavailability include the drug's formulation, the route of administration, the rate of absorption, and the first-pass metabolism effect, especially with oral medications that pass through the liver before reaching systemic circulation . Bioavailability is critical as it determines the drug's efficiency in reaching necessary therapeutic levels to produce the desired effect, which influences dosing and efficacy .
Prescription drugs are those that require a licensed healthcare provider’s authorization to be dispensed to a patient. They are typically used for more serious conditions and undergo rigorous testing and approval processes to ensure safety and efficacy . Non-prescription drugs, also known as over-the-counter (OTC) drugs, do not require a prescription and can be purchased directly by consumers for self-care. These drugs are generally used to treat less severe conditions and are considered safe for use without medical supervision if used as directed .
The FDA pregnancy categories are a system to classify the potential risks of drug use during pregnancy. Category A includes drugs with well-controlled studies indicating no risk to the fetus. Category B includes drugs with no evidence of harm in animal studies but without conclusive studies in humans. Category C involves drugs shown to have adverse effects on animal fetuses with no adequate human studies, potentially warranting use if benefits justify the risks. Category D drugs have evidence of human fetal risk, but the benefits may warrant use in pregnant women despite risks . These categories help healthcare providers make informed decisions regarding drug prescriptions during pregnancy.
A drug's chemical name provides a detailed description of its molecular structure, which is critical during its approval as it identifies the active compound's specific chemical properties. The official name, often the same as the generic name, simplifies this complex chemical identifier to a format that can be universally recognized in official references like the USPN/NF . This clear naming aids in classification by ensuring consistency and understanding among healthcare professionals, facilitating communication, regulatory processes, and ensuring safety during drug administration .
Metabolism refers to the process by which drugs are transformed into more water-soluble compounds, allowing for easier excretion from the body. This transformation often occurs in the liver and can result in either active/inactive metabolites that continue to exert effects until further metabolization occurs . First-pass metabolism is an important consideration for orally administered drugs as it describes the initial passage through the liver, potentially metabolizing a significant portion of the drug before it reaches systemic circulation, thus affecting the drug's availability and required dosing . Understanding this helps in determining the correct oral dosage to achieve the desired therapeutic effect.
Controlled substance schedules are categories that classify drugs based on their acceptable medical use and potential for abuse or dependence. Schedule I drugs are not approved for medical use and have high abuse potential. Schedule II drugs have accepted medical uses but high abuse potential. Schedule III drugs have lower abuse potential compared to Schedules I and II but can lead to dependence. Schedule IV drugs have a lesser potential for abuse, and Schedule V drugs contain moderate amounts of controlled substances and have the lowest abuse potential . This classification helps guide regulatory controls and prescribing practices to mitigate risks associated with drug abuse.
Contraindications are specific situations where a particular drug should not be used because it could be harmful to the patient. For instance, isotretinoin is contraindicated in pregnancy due to its teratogenic effects . Clinicians use this information to guide their prescribing decisions, ensuring that drugs are not administered in scenarios where they could cause significant harm, by considering patient-specific factors such as existing health conditions, other medications, and individual risk factors. This helps to optimize therapeutic outcomes and patient safety by avoiding adverse drug reactions .
Drug interactions can alter the effectiveness or increase the toxicity of drugs. Drug-drug interactions occur when one drug affects the action of another drug, potentially leading to enhanced or diminished effects or increased side effects . Drug-food interactions occur when nutrition or drink intake affects a drug's action, which can either impair or enhance drug absorption . Drug-supplement interactions involve dietary or herbal supplements, which may alter drug metabolism or efficacy. Each type of interaction varies based on the substances involved and can have significant implications for patient safety and therapeutic effectiveness .
During pregnancy, drug distribution can affect the fetus as drugs may cross the placental barrier, potentially posing risks depending on the drug category . During lactation, drugs can enter breast milk, affecting the nursing infant. This has treatment implications as healthcare providers must evaluate the safety and necessity of a medication, considering potential risks to the fetus or infant while aiming to provide effective treatment to the mother . Prescribing safer alternatives or adjusting dosages might be necessary to minimize adverse outcomes.